NCT04025463

Brief Summary

"Healing our Minds and Bodies" (HHMB) uses a a hybrid type II effectiveness/implementation study design to increase both patient and organizational readiness to address trauma and CVD risk among African American and Latino persons living with HIV or AIDS (PLWHIV).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
202

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2019

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 19, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

November 28, 2023

Status Verified

November 1, 2023

Enrollment Period

3.2 years

First QC Date

June 27, 2019

Last Update Submit

November 22, 2023

Conditions

Keywords

Implementation scienceOrganizational readinessAfrican AmericanLatino

Outcome Measures

Primary Outcomes (8)

  • Experience of workload

    Maslach Burnout Inventory - 16-item general survey measuring burnout in the workplace. Scale ranges from 0-6,with 0 = "Never" and 6 = "every day."

    Baseline

  • Implementation Climate Scale

    This 18-item measure assesses the degree to which there is a strategic organizational climate supportive of evidence-based practice implementation. Implementation climate is defined as employees' shared perceptions of the policies, practices, procedures, and behaviors that are rewarded, supported, and expected in order to facilitate effective EBP implementation. The scale ranges from 0-4, with 0 = "not at all" and 4 = "very great extent."

    Baseline

  • Implementation Leadership Scale

    The ILS assesses the degree to which a leader is Proactive, Knowledgeable, Supportive, and Perseverant in implementing evidence-based practice. The score for each subscale is created by computing a mean score for each set of items that load on a given subscale. For example, items 1, 2, and 3 constitute Scale 1. A mean of the scale scores may be computed to yield the mean score for the total ILS.

    Baseline

  • Implementation Citizenship Behavior Scale

    This measure assesses the behaviors employees perform that exceed their expected job tasks to support the implementation of evidence-based practices (EBPs). The score for each subscale is created by computing a mean score for each set of items that load on a given subscale. For example, items 1, 2, and 3 constitute Scale 1 (Helping Others). A mean of the scale scores may be computed to yield the mean score for the total ICBS.

    Baseline

  • Change from baseline in CVD Risk - Life's Simple Seven

    Seven risk factors that individuals can improve through lifestyle changes to help achieve ideal cardiovascular health

    Three-month Follow-up

  • Change from baseline in PROMIS V1.2 - Global Health

    Assessment of generic (not condition-specific) physical, mental, and social health. The adult PROMIS Global Health measure produces two scores: Physical Health and Mental Health.

    Three-month Follow-up

  • Change from baseline in Difficulties in Emotional Regulation (DERS)

    Self-report measure of six facets of emotion regulation. Items are rated on a scale of 1 ("almost never \[0-10%\]") to 5 ("almost always \[91-100%\]"). Higher scores indicate more difficulty in emotion regulation.

    Three-month Follow-up

  • Change from baseline in Woke Scale

    Measure of Critical Racial Consciousness

    Three-month Follow-up

Secondary Outcomes (9)

  • Change from baseline in Hill-Bone Adherence Scale

    Three-month Follow-up

  • Change from baseline in HIV Adherence Scale

    Three-month Follow-up

  • Change from baseline in Beck Depression Inventory-II

    Three-month Follow-up

  • Change from baseline in Overall Anxiety Severity and Impairment Scale (OASIS)

    Three-month Follow-up

  • Change from baseline in Post-traumatic Stress (PDS-5)

    Three-month Follow-up

  • +4 more secondary outcomes

Study Arms (1)

Intervention

OTHER

Hybrid type II effectiveness/implementation study design - pre-post design with each participant serving as his or her own control.

Behavioral: HHMB

Interventions

HHMBBEHAVIORAL

Blended, culturally-congruent, evidence-informed care model to increase patient and clinic participation in CVD risk reduction for patients with HIV

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Patient Eligibility
  • African American and Latino
  • Patient cared for in a participating agency
  • to 60 years of age
  • Living with HIV or AIDS
  • Speak English or Spanish
  • Screen greater than 0 on the UCLA Life Adversities Screener (LADS)
  • Identify at least one self-reported CVD risk factor
  • Known psychiatric, physical or neurological impairment that would limit their effective participation;
  • Recent history of a severe illness, sexual or physical abuse that might require sudden medical, psychological and/or legal intervention
  • Unwilling or unable to give consent or to commit to participate in the study through completion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

OASIS Clinic

Los Angeles, California, 90059, United States

Location

Northeast Valley Healthcare Corporation

Van Nuys, California, 91405, United States

Location

Related Publications (4)

  • Wyatt GE, Loeb TB, Cooley-Strickland M, Chin D, Wyatt LE, Smith-Clapham AM. Novel methodologies using history to document the effects of African American sexual trauma: Perspectives of Gail E. Wyatt, PhD. Am Psychol. 2023 May-Jun;78(4):563-575. doi: 10.1037/amp0001132.

    PMID: 37384508BACKGROUND
  • Loeb TB, Viducich I, Smith-Clapham AM, Adkins-Jackson P, Zhang M, Cooley-Strickland M, Davis T, Pemberton JV, Wyatt GE. Unmet need for mental health services utilization among under-resourced Black and Latinx adults. Fam Syst Health. 2023 Jun;41(2):149-159. doi: 10.1037/fsh0000750. Epub 2022 Dec 15.

    PMID: 36521110BACKGROUND
  • Loeb TB, Banks D, Ramm K, Viducich I, Beasley Q, Barron J, Chen EL, Norwood-Scott E, Fuentes K, Zhang M, Brown AF, Wyatt GE, Hamilton AB. Achieving Health Equity and Continuity of Care for Black and Latinx People Living With HIV. Am J Public Health. 2023 Jun;113(S2):S107-S109. doi: 10.2105/AJPH.2023.307222. No abstract available.

    PMID: 37339419BACKGROUND
  • Hamilton AB, Brown A, Loeb T, Chin D, Grills C, Cooley-Strickland M, Liu HH, Wyatt GE. Enhancing patient and organizational readiness for cardiovascular risk reduction among Black and Latinx patients living with HIV: Study protocol. Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):101-108. doi: 10.1016/j.pcad.2020.02.014. Epub 2020 Feb 25.

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromePsychological Trauma

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesStress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Gail Wyatt, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Hybrid type II effectiveness/implementation study design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 27, 2019

First Posted

July 19, 2019

Study Start

October 1, 2019

Primary Completion

November 30, 2022

Study Completion

May 31, 2023

Last Updated

November 28, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations